255 related articles for article (PubMed ID: 1671636)
21. [Arteriography in Raynaud's phenomenon].
Reggi M; Monin A; Courbier R
J Mal Vasc; 1986; 11(1):71-9. PubMed ID: 3944525
[TBL] [Abstract][Full Text] [Related]
22. The origin of Raynaud's phenomenon.
Nielubowicz J; Zajaç S; Szamowska R; Adamski M
J Cardiovasc Surg (Torino); 1978; 19(6):607-14. PubMed ID: 739033
[TBL] [Abstract][Full Text] [Related]
23. [Arteriographic data in chronic ischemia of the hand. Study of 62 cases].
Menanteau B; Treutenaere JM; Marcus C; Ladam V; Bonnet F
J Mal Vasc; 1986; 11(1):31-4. PubMed ID: 2868065
[TBL] [Abstract][Full Text] [Related]
24. [Polyarteritis nodosa. Considerations on a clinical case].
Pinto GM; Farinha O; Pacheco FA
Med Cutan Ibero Lat Am; 1990; 18(4):273-7. PubMed ID: 1981800
[TBL] [Abstract][Full Text] [Related]
25. Silent myocardial infarction subsequent to cutaneous polyarteritis nodosa in a patient with positive lupus anticoagulant.
Kawakami T; Akashi YJ; Soma Y
J Am Acad Dermatol; 2011 Aug; 65(2):442-443. PubMed ID: 21763578
[No Abstract] [Full Text] [Related]
26. [Contribution of methods of exploration of the distal vascular bed to the diagnosis and general comprehension of Raynaud's phenomenon].
Langeron P
Phlebologie; 1977; 30(2):189-98. PubMed ID: 905342
[TBL] [Abstract][Full Text] [Related]
27. Collagenous colitis and cutaneous polyarteritis nodosa in the same patient.
Procopiou M; Egger JF; De Torrenté A
Scand J Gastroenterol; 2004 Jan; 39(1):89-92. PubMed ID: 14992568
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous polyarteritis nodosa associated with hepatitis B surface antigen.
Whittaker SJ; Dover JS; Greaves MW
J Am Acad Dermatol; 1986 Nov; 15(5 Pt 2):1142-5. PubMed ID: 2877014
[TBL] [Abstract][Full Text] [Related]
29. A case of cutaneous polyarteritis nodosa with elevated serum interleukin-6 levels complicated by leg arterial stenosis and destructive arthropathy of the left ankle.
Horai Y; Tokuyama A; Sumiyoshi R; Nakashima Y; Suzuki T; Okada A; Kawashiri SY; Ichinose K; Izumi Y; Miyashita T; Tamai M; Yamasaki S; Nakamura H; Hayashi T; Origuchi T; Kawakami A
Mod Rheumatol; 2014 Jan; 24(1):206-11. PubMed ID: 24261780
[TBL] [Abstract][Full Text] [Related]
30. Inflammatory plaque with peripheral nodules: a new specific finding of cutaneous polyarteritis nodosa.
Chan PT; Ishiko A; Wada N; Yamamoto N; Amagai M
J Am Acad Dermatol; 2009 Feb; 60(2):320-5. PubMed ID: 19150276
[TBL] [Abstract][Full Text] [Related]
31. Cutaneous polyarteritis nodosa: report of case and literature review.
Avedisian R; Adelizzi RA
J Am Osteopath Assoc; 1985 Feb; 85(2):93-6. PubMed ID: 2858461
[No Abstract] [Full Text] [Related]
32. Chronic polyarthritis as the first manifestation of childhood systemic polyarteritis nodosa.
Novak GV; Hayashi K; Sampa K; Okumura Y; Ferreira GRV; Silva CA
Einstein (Sao Paulo); 2017; 15(1):96-99. PubMed ID: 28444097
[TBL] [Abstract][Full Text] [Related]
33. [Arteriographic study of the hand in 52 cases of Raynaud's phenomenon of varying aetiology (author's transl)].
Jeune R; Thivolet J
Nouv Presse Med; 1978 Sep; 7(30):2619-23. PubMed ID: 693297
[TBL] [Abstract][Full Text] [Related]
34. Cutaneous polyarteritis nodosa: a comprehensive review.
Morgan AJ; Schwartz RA
Int J Dermatol; 2010 Jul; 49(7):750-6. PubMed ID: 20618492
[TBL] [Abstract][Full Text] [Related]
35. Cutaneous polyarteritis nodosa sine nodosa.
Merman E; Rosen C; Ghazarian D; Al Habeeb A; Siddha S
J Cutan Med Surg; 2014 Nov; 18(6):420-3. PubMed ID: 25348764
[TBL] [Abstract][Full Text] [Related]
36. Renal angiogram abnormalities in a case of cutaneous polyarteritis nodosa.
Orton DI; Whittaker SJ
Clin Exp Dermatol; 2000 Jan; 25(1):33-5. PubMed ID: 10671968
[TBL] [Abstract][Full Text] [Related]
37. Doppler spectral waveform analysis of arteries of the hand in patients with Raynaud's phenomenon as compared with healthy subjects.
Chikui T; Izumi M; Eguchi K; Kawabe Y; Nakamura T
AJR Am J Roentgenol; 1999 Jun; 172(6):1605-9. PubMed ID: 10350298
[TBL] [Abstract][Full Text] [Related]
38. [Etiological profile of secondary Raynaud's phenomenon in an internal medicine department. About 121 patients].
Ben Salem T; Tougorti M; Bziouech S; Lamloum M; Khanfir M; Ben Ghorbel I; Houman MH
J Med Vasc; 2018 Feb; 43(1):29-35. PubMed ID: 29425538
[TBL] [Abstract][Full Text] [Related]
39. A suspicious reason for Raynaud's phenomenon: Intrauterine device.
Diken AI; Yalçınkaya A; Aksoy E; Yılmaz S; Çağlı K
Vascular; 2015 Jun; 23(3):327-8. PubMed ID: 25348785
[TBL] [Abstract][Full Text] [Related]
40. Successful treatment of patients with severe secondary Raynaud's phenomenon with the endothelin receptor antagonist bosentan.
Selenko-Gebauer N; Duschek N; Minimair G; Stingl G; Karlhofer F
Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii45-8. PubMed ID: 16987835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
